Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seubert

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Brain Research|September 13, 1988
Stimulation of NMDA receptors induces proteolysis of spectrin in hippocampusP Seubert, J Larson, M Oliver, et al.
Brain Research|September 6, 1988
Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus. I. Biochemical studiesP Seubert, G Ivy, J Larson, et al.
The Biochemical Journal|June 1, 1996
Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356J M Litersky, G V Johnson, R Jakes, et al.
Journal of Neurochemistry|January 1, 1997
The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragmentsG V Johnson, P Seubert, T M Cox, et al.
Neurology|March 1, 1997
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's diseaseD Galasko, C Clark, L Chang, et al.
Biochemical and Biophysical Research Communications|May 16, 1994
Identification of secreted beta-amyloid precursor protein binding sites on intact human fibroblastsK L Johnson-Wood, T Henriksson, P Seubert, et al.
International Journal of Geriatric Psychiatry|December 16, 1998
Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's diseaseR A Lasser, R Dukoff, J Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activitiesM Citron, T S Diehl, G Gordon, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 22, 1999
Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's diseaseP L Moriearty, P Seubert, D Galasko, et al.
Nature Medicine|December 1, 1995
The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathwayC Haass, C A Lemere, A Capell, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Brain Research|September 13, 1988
Stimulation of NMDA receptors induces proteolysis of spectrin in hippocampusP Seubert, J Larson, M Oliver, et al.
Brain Research|September 6, 1988
Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus. I. Biochemical studiesP Seubert, G Ivy, J Larson, et al.
The Biochemical Journal|June 1, 1996
Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356J M Litersky, G V Johnson, R Jakes, et al.
Journal of Neurochemistry|January 1, 1997
The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragmentsG V Johnson, P Seubert, T M Cox, et al.
Neurology|March 1, 1997
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's diseaseD Galasko, C Clark, L Chang, et al.
Biochemical and Biophysical Research Communications|May 16, 1994
Identification of secreted beta-amyloid precursor protein binding sites on intact human fibroblastsK L Johnson-Wood, T Henriksson, P Seubert, et al.
International Journal of Geriatric Psychiatry|December 16, 1998
Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's diseaseR A Lasser, R Dukoff, J Levy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activitiesM Citron, T S Diehl, G Gordon, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 22, 1999
Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's diseaseP L Moriearty, P Seubert, D Galasko, et al.
Nature Medicine|December 1, 1995
The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathwayC Haass, C A Lemere, A Capell, et al.
Pageof 6